Cargando…
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
BACKGROUND: Antipsychotic-induced weight gain is a common and debilitating side effect of antipsychotics. Although genome-wide association studies of antipsychotic-induced weight gain have been performed, few genome-wide loci have been discovered. Moreover, these genome-wide association studies have...
Autores principales: | ter Hark, Sophie E, Jamain, Stéphane, Schijven, Dick, Lin, Bochao D, Bakker, Mark K, Boland-Auge, Anne, Deleuze, Jean-François, Troudet, Réjane, Malhotra, Anil K, Gülöksüz, Sinan, Vinkers, Christiaan H, Ebdrup, Bjørn H, Kahn, René S, Leboyer, Marion, Luykx, Jurjen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222287/ https://www.ncbi.nlm.nih.gov/pubmed/32126890 http://dx.doi.org/10.1177/0269881120907972 |
Ejemplares similares
-
Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)
por: Pandit, R., et al.
Publicado: (2019) -
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019) -
Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019) -
Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study
por: van der Meer, Dennis, et al.
Publicado: (2020) -
Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study – ERRATUM
por: van der Meer, Dennis, et al.
Publicado: (2020)